Joshua B. Cohen, Co-Chief Executive Officer at Amylyx Pharmaceuticals, Inc. (AMLX), sold 5,968 shares at $36.08 ($217K) on 2023-01-06, disclosed to the SEC on 2023-01-10.
Scheduled sale ($217k) by Co-Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.08 | 4,122 | $149K | 68.7% |
| 2 | $36.79 | 1,846 | $68K | 31.3% |
| Total | $36.30 avg | 5,968 | $217K | 100% |
| Filing → |
| AMLX | SELL | 2026-02-04 | $228K | — | Filing → |
| AMLX | SELL | 2026-01-20 | $1.9M | — | Filing → |
| AMLX | SELL | 2026-01-08 | $86K | — | Filing → |